HHS Rebate Reform: An Air Of Inevitability In Stakeholder Comments

 
• By Cathy Kelly

Manufacturers, pharmacy benefit managers and insurers weigh in on the Trump administration’s most significant drug pricing action to date – the HHS Office of Inspector General's proposed rule aimed at eliminating rebates.

Bright white clouds and dark grey clouds against a blue sky; Storm clouds are coming; Cumulus clouds and thunderclouds
Manufacturers staunchly support the January 2020 start date of rebate reform but say it will take time to set up the new infrastructure needed.

More from Market Access

More from Pink Sheet